Euronav NV (NYSE:CMBT – Get Free Report) was the target of a large increase in short interest in September. As of September 15th, there was short interest totalling 230,300 shares, an increase of 8.5% from the August 31st total of 212,200 shares. Currently, 1.5% of the company’s shares are short sold. Based on an average trading volume of 159,400 shares, the days-to-cover ratio is currently 1.4 days.
Euronav Price Performance
Euronav stock traded up $0.20 during midday trading on Tuesday, reaching $16.82. The stock had a trading volume of 138,176 shares, compared to its average volume of 674,189. Euronav has a twelve month low of $14.10 and a twelve month high of $21.26. The company has a debt-to-equity ratio of 1.54, a quick ratio of 1.32 and a current ratio of 1.37. The firm has a market cap of $3.39 billion, a price-to-earnings ratio of 7.45 and a beta of -0.08. The firm has a fifty day moving average of $16.40.
Euronav (NYSE:CMBT – Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported $0.46 EPS for the quarter, topping the consensus estimate of $0.24 by $0.22. The business had revenue of $233.66 million during the quarter. Euronav had a return on equity of 22.35% and a net margin of 112.38%. As a group, sell-side analysts predict that Euronav will post 1.46 EPS for the current fiscal year.
Euronav Announces Dividend
Euronav Company Profile
Euronav NV, together with its subsidiaries, engages in the transportation and storage of crude oil worldwide. The company offers floating, storage, and offloading (FSO) services. It also owns and operates a fleet of vessels. The company was incorporated in 2003 and is headquartered in Antwerp, Belgium.
Read More
- Five stocks we like better than Euronav
- What is a Secondary Public Offering? What Investors Need to Know
- Why Lennar Stock Could Be the Best Play in the Housing Market
- CD Calculator: Certificate of Deposit Calculator
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Insider Buying Explained: What Investors Need to Know
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Euronav Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Euronav and related companies with MarketBeat.com's FREE daily email newsletter.